Although Simpson et al. demonstrated that an αCTLA-4 mAb depletes Tregs in B16F10 tumors (48), it should be noted that host animals also received an irradiated B16-BL6 tumor cell–based vaccine that secretes GM-CSF (GVAX) to boost macrophage infiltration. The gene discussed is CSF2; the disease is neoplasm.